Ladenburg Thalmann Financial Services’s Aptose Biosciences, Inc. APTO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6	Closed	-$7.82K	–	5004
2019 Q3	$6K	Buy	+6	New	+$6.83K	﹤0.01%	4638
2019 Q1	–	Sell	-13	Closed	-$11K	–	5396
2018 Q4	$11K	Hold	13	–	–	﹤0.01%	4239
2018 Q3	$16K	Sell	13 -120	-90%	-$161K	﹤0.01%	4050
2018 Q2	$190K	Hold	133	–	–	﹤0.01%	2279
2018 Q1	$190K	Buy	+133	New	+$178K	﹤0.01%	2279

Other funds holding APTO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Ladenburg Thalmann Financial Services's APTO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services sold out of Aptose Biosciences, Inc. (APTO) in Q4 2019, closing a stake of 6 shares — an estimated $7.82K sold.

Ladenburg Thalmann Financial Services first reported a position in APTO in Q1 2018 and held it in 5 quarters. The position peaked at $190K in Q2 2018. 56 funds tracked by Wall St. Rank hold APTO as of Q4 2019.

Ladenburg Thalmann Financial Services reported no remaining Aptose Biosciences, Inc. position as of Q4 2019 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 6 Aptose Biosciences, Inc. shares in Q4 2019, an estimated $7.82K.
Ladenburg Thalmann Financial Services first reported a position in Aptose Biosciences, Inc. in Q1 2018 and held it in 5 quarters.
Ladenburg Thalmann Financial Services's Aptose Biosciences, Inc. position peaked at $190K in Q2 2018.
56 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.